BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| syzygium aromaticum {clove} - Escherichia coli APEC O1 |
👶
Antibacterial activity of cinnamaldehyde and clove oil: effect on selected foodborne pathogens in model food systems and watermelon juice. Journal of food science and technology (J Food Sci Technol ) Vol: 52 Issue 9 Pages: 5834-41 Pub: 2015 Sep Epub: 2014 Nov 14 Authors Siddiqua S , Anusha BA , Ashwini LS , Negi PS , Html Article Publication |
| syzygium aromaticum {clove} - Escherichia coli APEC O1 |
👶
Isoeugenol has a non-disruptive detergent-like mechanism of action. Frontiers in microbiology (Front Microbiol ) Vol: 6 Issue Pages: 754 Pub: 2015 Epub: 2015 Jul 28 Authors Hyldgaard M , Mygind T , Piotrowska R , Foss M , Meyer RL , Html Article Publication |
| syzygium aromaticum {clove} - Escherichia coli APEC O1 |
👶
Synergistic antimicrobial activities of natural essential oils with chitosan films. Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 59 Issue 23 Pages: 12411-9 Pub: 2011 Dec 14 Epub: 2011 Nov 9 Authors Wang L , Liu F , Jiang Y , Chai Z , Li P , Cheng Y , Jing H , Leng X , Publication |
| syzygium aromaticum {clove} - Escherichia coli APEC O1 |
👶
Biodegradable gelatin-chitosan films incorporated with essential oils as antimicrobial agents for fish preservation. Food microbiology (Food Microbiol ) Vol: 27 Issue 7 Pages: 889-96 Pub: 2010 Oct Epub: 2010 May 15 Authors Gómez-Estaca J , López de Lacey A , López-Caballero ME , Gómez-Guillén MC , Montero P , Publication Publication |
| syzygium aromaticum {clove} - Escherichia coli APEC O1 |
👶
Antimicrobial activity of spices essential oils and its effectiveness on mature biofilms of human pathogens. Natural product research (Nat Prod Res ) Vol: Issue Pages: 1-8 Pub: 2018 Oct 13 Epub: 2018 Oct 13 Authors Condò C , Anacarso I , Sabia C , Iseppi R , Anfelli I , Forti L , de Niederhäusern S , Bondi M , Messi P , Publication Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
